The effects of probiotics administration on the gut microbiome in adolescents with anorexia nervosa-A study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial.
anorexia nervosa
gut microbiome
gut-brain axis
probiotics
randomized controlled trial
Journal
European eating disorders review : the journal of the Eating Disorders Association
ISSN: 1099-0968
Titre abrégé: Eur Eat Disord Rev
Pays: England
ID NLM: 9436977
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
11
11
2021
received:
13
07
2021
accepted:
13
11
2021
pubmed:
2
12
2021
medline:
29
3
2022
entrez:
1
12
2021
Statut:
ppublish
Résumé
Knowledge on gut-brain interaction might help to develop new therapies for patients with anorexia nervosa (AN), as severe starvation-induced changes of the microbiome (MI) do not normalise with weight gain. We examine the effects of probiotics supplementation on the gut MI in patients with AN. This is a study protocol for a two-centre double-blind randomized-controlled trial comparing the clinical efficacy of multistrain probiotic administration in addition to treatment-as-usual compared to placebo in 60 patients with AN (13-19 years). Moreover, 60 sex- and age-matched healthy controls are included in order to record development-related changes. Assessments are conducted at baseline, discharge, 6 and 12 months after baseline. Assessments include measures of body mass index, psychopathology (including eating-disorder-related psychopathology, depression and anxiety), neuropsychological measures, serum and stool analyses. We hypothesise that probiotic administration will have positive effects on the gut microbiota and the treatment of AN by improvement of weight gain, gastrointestinal complaints and psychopathology, and reduction of inflammatory processes compared to placebo. If probiotics could help to normalise the MI composition, reduce inflammation and gastrointestinal discomfort and increase body weight, its administration would be a readily applicable additional component of multi-modal AN treatment.
Identifiants
pubmed: 34851002
doi: 10.1002/erv.2876
pmc: PMC9300207
doi:
Banques de données
DRKS
['DRKS00017726']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
61-74Informations de copyright
© 2021 The Authors. European Eating Disorders Review published by Eating Disorders Association and John Wiley & Sons Ltd.
Références
Science. 2013 Feb 1;339(6119):548-54
pubmed: 23363771
Nature. 2018 Mar 29;555(7698):623-628
pubmed: 29555994
Nat Commun. 2020 Jan 17;11(1):362
pubmed: 31953381
Complement Ther Med. 2020 Mar;49:102361
pubmed: 32147043
Front Cell Neurosci. 2015 Oct 14;9:392
pubmed: 26528128
Am J Clin Nutr. 2019 May 1;109(5):1402-1413
pubmed: 31051507
Cognition. 1994 Apr-Jun;50(1-3):7-15
pubmed: 8039375
Int J Eat Disord. 2021 Jun;54(6):969-980
pubmed: 33314258
J Psychiatr Res. 2015 Sep;68:228-37
pubmed: 26228424
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Int J Eat Disord. 2020 Aug;53(8):1303-1312
pubmed: 32359125
Alcohol Res. 2015;37(2):223-36
pubmed: 26695747
Gut Microbes. 2018 Nov 2;9(6):486-496
pubmed: 29723105
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
J Affect Disord. 2019 Jun 1;252:271-277
pubmed: 30991255
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Br J Pharmacol. 2018 Dec;175(24):4430-4438
pubmed: 29243233
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110114
pubmed: 32971217
J Neurosci. 2009 Feb 4;29(5):1538-43
pubmed: 19193900
Gut Microbes. 2012 Jan-Feb;3(1):29-34
pubmed: 22555633
Nutrients. 2017 Sep 15;9(9):
pubmed: 28914794
J Clin Med. 2021 Jul 20;10(14):
pubmed: 34300355
J Neurosci Methods. 2018 Jan 01;293:191-198
pubmed: 28970163
Transl Psychiatry. 2015 Oct 06;5:e652
pubmed: 26440540
Am J Psychiatry. 2017 Jun 1;174(6):557-565
pubmed: 28231717
Nat Rev Immunol. 2022 Jan;22(1):33-46
pubmed: 34002068
PeerJ. 2016 Oct 18;4:e2584
pubmed: 27781170
Psychiatry Res. 2012 Dec 30;200(2-3):518-23
pubmed: 22657951
Eur Child Adolesc Psychiatry. 2017 Sep;26(9):1031-1041
pubmed: 28144744
Int J Eat Disord. 2006 Nov;39(7):590-3
pubmed: 16826575
Aliment Pharmacol Ther. 2018 Apr;47(8):1054-1070
pubmed: 29460487
Eur Child Adolesc Psychiatry. 2017 Dec;26(12):1483-1499
pubmed: 28540609
Eur J Nutr. 2019 Aug;58(5):1821-1827
pubmed: 29850990
Sci Rep. 2016 May 27;6:26752
pubmed: 27229737
J Psychiatr Res. 2021 Jan;133:156-165
pubmed: 33341454
Eur J Clin Nutr. 2016 Feb;70(2):194-8
pubmed: 26419195
J Affect Disord. 2020 Apr 1;266:1-13
pubmed: 32056863
Nutr Res. 2009 Jan;29(1):1-7
pubmed: 19185771
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110187
pubmed: 33271210
Eur Eat Disord Rev. 2022 Jan;30(1):61-74
pubmed: 34851002
Psychopharmacology (Berl). 2019 May;236(5):1513-1530
pubmed: 30982128
J Neural Transm (Vienna). 2016 Aug;123(8):949-59
pubmed: 27188331
FEMS Microbiol Rev. 2015 Jul;39(4):509-21
pubmed: 25701044
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Nutr Res. 2016 Sep;36(9):889-898
pubmed: 27632908
Curr Neuropharmacol. 2018;16(8):1131-1149
pubmed: 29345582
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E139-48
pubmed: 24277822
Cell Rep. 2016 May 31;15(9):1945-56
pubmed: 27210745
World J Biol Psychiatry. 2018 Apr;19(3):225-235
pubmed: 28132573